GlassScriptPhysician profile
Laura Roden
NPI 1346592805
$1,414.59
in general payments reported to CMS, 2019-2025
23 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $440 · 2023: $244 · 2024: $255 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $310.59 | 2021-2025 | |
| Axonics, INC. | $141.23 | 2022 | |
| Exact Sciences Corporation | $116.86 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $101.80 | 2023-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $84.38 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $69.04 | 2021-2023 | |
| Vertex Pharmaceuticals Incorporated | $68.99 | 2025 | |
| Hologic Sales and Service, LLC | $62.61 | 2022-2025 | Thinprep 2000 Processor, Aptima |
| Sumitomo Pharma America, INC. | $53.29 | 2024 | Myfembree |
| Mayne Pharma Commercial LLC | $47.20 | 2025 | |
| Ethicon US, LLC | $43.78 | 2022-2025 | Dermabond Prineo, Ethicon, Stratafix |
| Therapeuticsmd, INC. | $43.49 | 2022 | |
| Novo Nordisk INC | $37.48 | 2022 | |
| Scynexis, INC. | $33.62 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $27.50 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $27.04 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Heron Therapeutics, INC. | $26.23 | 2023 | Zynrelef |
| Baxter Healthcare | $24.81 | 2025 | Perclot |
| Myovant Sciences INC. | $23.09 | 2022 | |
| Exeltis, USA INC. | $21.40 | 2023 | Slynd |
| Biogen, INC. | $19.60 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $16.51 | 2025 | Phexxi, Solosec, Phexx |
| Smith+Nephew, INC. | $14.05 | 2025 | Pico 14 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Roden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.